0.38 (-0.08%)
As of Feb 17, 2023
Source:
Perspective Therapeutics, Inc is developing the next generation of precision-targeted alpha therapies (“TAT”) for oncology that have the potential to treat a large population of cancer patients across multiple tumor types, including those with metastatic disease.
| Country | United States |
| Headquarters | seattle, washington |
| Phone Number | (206) 676-0900 |
| Industry | manufacturing |
| CEO | Johan (Thijs) Spoor |
| Website | www.perspectivetherapeutics.com |